Endo International Ordinary Shares reported $135.07M in Interest Expense on Debt for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Aerie Pharmaceuticals AERI:US $ 1.64M 0M
Bristol Myers Squibb BMY:US $ 313M 13M
Eli Lilly And LLY:US $ 81.2M 3.7M
Lannett LCI:US $ 14.52M 0.09M
Novartis NOVN:VX 202M 1000K
Pacira Pharmaceuticals PCRX:US $ 8.83M 1.41M
Pfizer PFE:US $ 293M 29M
Phibro Animal Health PAHC:US $ 3.11M 0.01M
Revance Therapeutics RVNC:US $ 3.87M 1.94M
Supernus Pharmaceuticals SUPN:US $ 1.81M 0.66M
Teva Pharmaceutical TEVA:IT 225M 13M
Xeris Pharmaceuticals Inc XERS:US $ 3.45M 73K
Zoetis ZTS:US $ 53M 0M